On ECHEMI
Home > Drugs > Myelopathy due to systemic lupus erythematosus
Myelopathy due to systemic lupus erythematosus
Myelopathy caused by systemic lupus erythematosus (SLE) is the manifestation of SLE lesions in the spinal cord. SLE is a specific autoimmune disease involving multiple factors (genetics, sex hormones, environment, infection, drugs, and immune response), which can affect multiple systems, so symptoms of multi-organ damage appear. At the beginning of the disease, there are often irregular fevers, with skin damage being the most common, butterfly-shaped erythema on the cheeks and bridge of the nose, and rashes may also occur on the neck or trunk; in addition, joint pain and lymphadenopathy are often associated. Damage to the central nervous system caused by SLE is the main cause of death, which is statistically between 20% and 60%, and some reports can be as high as 75% (Johnson, 1968). Recurrent convulsions are the most common, followed by cranial nerve disorders, mental disorders, cerebrovascular accidents, increased intracranial pressure and meningitis, involuntary movements, and peripheral nerve damage such as Raynaud's phenomenon.
  • Site of disease:

    Spinal cord immune system
  • Infectious :

    Not contagious
  • Frequent population:

    Patients with systemic lupus erythematosus
  • Related symptoms:

    Facial butterfly erythema thrombocytopenia photoallergy spinal cord lesions paraplegia
  • Concurrent disease:

Related Drugs
Prednisolone
Indication: No data yet
Manufacturer:

Tianjin Jinjin Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.